Fletcher Aaron G.L.'s Form 4 filing
IN8BIO, Inc. (INAB) · filed Aug 18, 2022
- Accession no.
- 0001104659-22-092665
- Filed
- Aug 18, 2022, 7:16 PM ET
- Trade date
- Aug 17, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $96.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fletcher Aaron G.L.CIK 0001789490 | Director, 10% Owner |
| Cavu Management, LPCIK 0001813270 | Director, 10% Owner |
| BIOS Advisors GP, LLCCIK 0001813844 | Director, 10% Owner |
| BIOS Capital Management, LPCIK 0001813845 | Director, 10% Owner |
| BIOS Equity Partners III, LPCIK 0001831976 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | Common Stock | PPurchaseAcquired | +6,142 | $1.93 | +$11,854.06 | 583,407 | Indirect | |
| Aug 17, 2022 | Common Stock | PPurchaseAcquired | +38,035 | $1.93 | +$73,407.55 | 3,612,569 | Indirect | |
| Aug 17, 2022 | Common Stock | PPurchaseAcquired | +5,823 | $1.93 | +$11,238.39 | 553,110 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.